06 February 2024>: Original Paper
Immunoprotective Effect of Liver Allograft on Patients with Combined Liver and Kidney Transplantation
Joon-Young Kim 1BCDEF* , Hye Bin Kim 2BCDEF* , Jin-Myung Kim 1BCD , Hye Eun Kwon 1BCD , Young Hoon Kim 1BCD , Youngmin Ko 1BCD , Frances S. Sung 1BCD , Joo Hee Jung 1BC , Chung Hee Baek 3B , Hyosang Kim 3B , Su-Kil Park 3B , Sung Shin 1BCD , Hyunwook Kwon 1ABCDEF*DOI: 10.12659/AOT.942763
Ann Transplant 2024; 29:e942763
Supplementary Table 1 Comparative analysis of rejection types and incidences.
KTA (n=4268) | LTKT (n=44) | P-value | |
---|---|---|---|
1-year rejection | 384 (9.0%) | 2 (4.5%) | 0.43 |
Overall rejection | 973 (22.8%) | 3 (6.8%) | 0.012 |
ACR only | 380 (8.9%) | 2 (4.5%) | 0.49 |
AMR only | 77 (1.8%) | 0 (0%) | |
ACR+AMR | 510 (11.9) | 3 (6.8%) | |
ACR – acute cellular rejection; AMR – acute antibody-mediated rejection. |